Unless you’re allergic to certain non-active ingredients or have you have an unusual sensitivity, generally the brand-name and generic versions of over-the-counter medicines are pretty much the same. Manufacturers keep adding innovations to coax customers away from generic meds, like a film-coated version of Pfizer’s Advil that is supposed to relieve pain faster. Does it? [More]
Yeah, buying generics drugs instead of their snazzy brand name versions could stifle an allergy, calm a nasty cough or banish that throb on the cheap. But at more than half the price? [More]
There are some people out there who just don’t get how much crazy money you can save with buying generic drugs. For those folks, this infographic was crafted by Mint.com. To illustrate the cost-savings possible, they took a look at Advil. For the same 200 mg of isobutylpropanoicphenolic acid, people are willing to pay over $8 more per box. Those pretty graphics aren’t going to chase away your headache any faster, honey. Let’s take a look: [More]
A new ad for Celebrex, a prescription painkiller related to Vioxx, has come under fire for implying that Celebrex is as safe as non-prescription painkillers such as ibuprofen (Advil, Motrin) and naproxen (Aleve.) A consumer group has written a letter to the FDA requesting that they ban the ad, claiming that it contains “false or misleading statements.”
“The overall purpose of the ad is to make it appear, contrary to scientific evidence, that the cardiovascular dangers of Celebrex are not greater than those of any of the other Nsaid painkillers,” the letter said, referring to nonsteroidal anti-inflammatory drugs. “Further, it asserts that certain gastrointestinal problems are, if anything, less frequent with Celebrex than with two popular over-the-counter (OTC) painkillers.”
The ad, which is two-and-a-half minutes long (Pfizer was the only sponsor of the program on which it aired), can be viewed at Celebrex.com. The ad marks Celebrex’s return to advertising after a two year hiatus following Vioxx’s withdrawal from the market due to dangerous cardiovascular side-effects.
“Non-prescription pain relievers used by millions of U.S. consumers need stronger health warnings regarding liver or stomach risk, the Food and Drug Administration said Tuesday.” The drugs in questions are acetaminophen (Tylenol), and NSAIDs like ibuprofen (Advil, Motrin). In particular acetaminophen is associated with liver problems.